Background and aims Prior research has found bidirectional associations between psychotic experiences (PEs) and se-
INTRODUCTION
Although it is widely acknowledged that acute intoxication with various legal and illicit substances can be associated with transient hallucinatory and delusional experiences, community surveys have also linked substance use (SU; i.e. the use of a particular substance, but not meeting diagnostic criteria for a disorder) and substance use disorders (SUDs) with an increased risk of psychotic experiences (PEs), outside periods of acute intoxication or withdrawal [1] [2] [3] [4] [5] [6] . In particular, there is a body of evidence linking cannabis use with an elevated risk of PEs [1] [2] [3] [4] [5] [7] [8] [9] . Recent studies have also linked commonly used substances such as tobacco and alcohol with PEs [4, [10] [11] [12] [13] . For example, a 44-country study from the World Health Survey found that current tobacco smoking was associated with increased odds of life-time PEs (OR = 1.35; 95% CI = 1.27-1.43) [10] . Illicit drugs including cocaine, amphetamines and opioids have also been linked with PEs [14] [15] [16] [17] .
Curiously, there is evidence that the relationship between PEs and SU/SUDs may be bidirectional. In our earlier paper, we found that substance use disorders (particularly alcohol abuse and dependence) were associated bidirectionally with PEs [18] . Several cohort studies have found bidirectional association between PEs and cannabis use disorders [1, 2, 9, 19, 20] . These findings highlight the importance of understanding the temporal sequence of PEs and SU/SUDs. There is also strong evidence that familial factors may confound the apparent relationship between cannabis use and subsequent psychotic disorders [21] . Based on these findings, there is a need for studies that use temporally ordered variables to explore the bidirectional associations between PEs and different types of SUs (e.g. tobacco, cannabis, cocaine, alcohol, prescription drugs, other illicit drugs). More complex models are also required in order to determine how various types of SU/SUDs influence the association between SU/SUDs and PEs. For example, it is feasible that the presence of mental disorders can influence the onset of PEs (e.g. a substance use disorder may lead to a major depression, which leads in turn to the onset of PEs). There is evidence that those with SU/SUDs have an increased risk of mental disorders [22, 23] , and there is a bidirectional relationship between PEs and mental disorders [18] . Thus, it is reasonable to assume that the association between PEs and SU/SUDs may be explained at least in part by antecedent mental disorders. Finally, there is a need to explore if there is a 'doseresponse' relationship between PEs (e.g. number of types of PEs and frequency of PE episodes) and subsequent odds of SU/SUDs.
The aims of the study were to extend previous findings by examining: (1) the association between SUs or SUDs and the subsequent onset of PEs; and conversely, (2) the association between prior PEs and subsequent onset of SUs and SUDs, (3) the influence of number or types of PEs and (4) antecedent mental disorders together with comorbid SU/SUDs on these associations.
METHODS

Samples
Data were drawn from 18 WMH surveys from the World Health Organization (WHO) World Mental Health surveys that included both the WHO Composite International Diagnostic Interview (CIDI) psychosis module and items related to substance use. A multi-stage clustered area probability sampling strategy was used to select respondents in majority of the surveys except for Belgium, Germany and Italy. These three countries used municipal resident registries to select respondents without listing households. Details of each survey are presented in the Supporting information, Table S1 . The weighted average response rate across all 18 surveys was 71.7%. Further information on samples used for different substance use, details of procedure and the assessment of mental disorders can be found in the Supporting information, Table S2 .
Measures
Tobacco, alcohol and illicit drug use All WMH surveys used the WHO CIDI (3.0), a fully structured diagnostic interview administered by trained lay interviewers. Details of the assessments of tobacco, alcohol and illicit drug use have been published elsewhere [24] . The tobacco and substance-use module of the CIDI includes an assessment of life-time occurrence and age at first initiation of alcohol, tobacco and each illicit drug use. Respondents were asked if they had ever (i) used cigarettes, cigars or pipe (tobacco use), (ii) smoked tobacco daily for a period of at least 2 months (daily tobacco use), (iii) drank alcohol (alcohol use), (iv) either marijuana or hashish (cannabis use), (v) used cocaine in any form including powder, crack, free base, coca leaves or paste (cocaine use), (vi) used tranquillizers, stimulants, pain-killers or other prescription drugs for non-medical reasons or without the recommendation of a health professional (henceforth extra-medical prescription drug use) or (vii) used other drug such as heroin, opium, glue, lysergic acid diethylamide (LSD), peyote or any other drug (other illicit drug use).
Substance use disorders
The WHO CIDI version 3.0 was used to generate DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th edition) substance abuse or dependence disorders diagnoses. The substance use disorders were nicotine dependence, alcohol abuse, alcohol dependence, illicit drug abuse and illicit drug dependence. The CIDI 3.0 does not allow for the diagnosis of cannabis use and/or dependence disorder because there was no separate question for cannabis use or dependence. Some of the assessment details of these disorders have been published elsewhere [25, 26] . Standard hierarchy rules were applied, such that people meeting criteria for DSM-IV dependence could not also meet criteria for abuse for that substance.
A series of five questions was used to operationalize the symptom criteria for alcohol abuse and a further 11 questions for alcohol dependence. These were asked of respondents who (in the year they drank most) consumed alcohol at or above a certain quantity/frequency threshold of one or more drinks per week or, if drinking less often, three or more drinks per day on the days they drank. For extra-medical prescription drug use and illicit drug use disorders, respondents were asked if they had ever used medicines for non-medical reasons or had ever used illicit drugs, respectively. Those who reported life-time use were then asked a series of questions: four questions for assessing DSM-IV drug abuse and 11 questions to assess for drug dependence (mapping to the seven DSM-IV criteria). Nicotine dependence was assessed using a similar method.
Respondents who reported smoking weekly were asked a series of questions about the symptoms of nicotine dependence (e.g. tolerance, withdrawal, smoking in larger amounts or longer than intended, etc.). A number of initial surveys in the WMH survey initiative (13 in this study) only assessed symptoms of dependence among respondents without a history of abuse. In order to improve the crossnational comparability of estimates of SUDs, estimates for alcohol and illicit drug dependence were used in these surveys based on the method described in Lago et al. [27] .
Psychotic experiences (PEs)
The CIDI Psychosis Module included questions about six PE types-two related to hallucinatory experiences (visual hallucinations, auditory hallucinations) and four related to delusional experiences (thought insertion/withdrawal, mind control/passivity, ideas of reference, plot to harm/follow) (Supporting information, Table S2a, S2b). The respondents were asked if they ever experienced each PE (e.g. 'Have you ever seen something that wasn't there that other people could not see?'; 'Have you ever heard any voices that other people said did not exist?', etc.). Only PEs occurring when the person was 'not dreaming, not half-asleep, or not under the influence of alcohol or drugs' were included. With respect to the current research questions, it is important to note that hallucinations or delusions that occurred 'under the influence of alcohol or drugs' were excluded from all analyses. Age-at-onset of respondents with PEs was also assessed. In this paper, we present two key PE-related metrics: (a) number of PE types (henceforth referred to as PE-type metric); and (b) frequency of occurrence of PE episodes. We derived frequency per year by dividing the number of PE episodes by the time since onset of the PEs (age at interview minus age of onset, henceforth referred to as annualized frequency metric [28] .
Statistical analysis
In order to focus on the correlates of PEs in those without psychotic disorders, we made the a priori decision to exclude individuals who had PEs but who also screened positive for possible schizophrenia/psychosis or manic-depression/mania. In keeping with previous publications [4, 18, [28] [29] [30] we excluded respondents who: (a) reported (1) schizophrenia/ psychosis or (2) manicdepression/mania in response to the question: 'What did the doctor say was causing (this/these) experiences?'; and (b) those who ever took any antipsychotic medications for these symptoms. This resulted in the exclusion of 139 respondents (0.4% of all respondents), leaving 30 902 respondents for this study (Supporting information, Table S1 ).
The association between SU/SUDs and PEs was tested using the Rao-Scott χ
2
. Discrete-time survival models We also examined a model that adjusted further for the presence of other antecedent SU/SUDs (M2), and then additionally for the presence of other antecedent mental disorders (M3) (details can also be seen in Tables 2 and 3) . We also conducted two additional analyses: (1) to explore the impact of severity of PEs we repeated the survival models (M3) for prior PEs to predict subsequent onset of SU/SUDs using measures for both PE type metric (two or more types versus one type) and PE annualized frequency metric (dichotomized with a median split -more than 0.3 versus 0.3 or less episodes per year) in the models; and (2) a post-hoc analysis examining the associations between PEs and subsequent onset of SUDs among those with substance use only.
As the WMH data are both clustered and weighted, the design-based Taylor series linearization implemented in version 11 of SUDAAN software was used to estimate standard errors and evaluate the statistical significance of coefficients. All significance tests were evaluated using 0.05-level two-sided tests.
RESULTS
The life-time prevalence of SU/SUDs for the total sample and respondents with and without PEs are shown in Table 1 . Among the total sample 74.7% [standard error (SE) = 0.4] of the respondents reported alcohol use while only 7.7% (SE = 0.2) met criteria for alcohol use disorders. Similarly, 51.0% (SE = 0.6) of the respondents reported tobacco use, whereas only 15.1% (SE = 0.4) had nicotine dependence disorders. Overall, the prevalence of all measures of SU/SUDs were higher among those with PEs compared with those without PEs (χ 2 1 ranges between 24.2 and 162.5, P < 0.001). Associations between substance use, substance use disorders and subsequent onset of psychotic experiences First, we examined the associations between SUs and SUDs, and the subsequent onset of PEs in the total sample (Table 2 ). In the multivariable base model (M1) adjusting for age-cohort, sex, person-years and country, all substance use or SUDs were associated significantly with increased odds of subsequent onset of PEs. In the multivariate model (M2), after adjusting for potential confounding factors that included age-cohort, sex, person-years, country and temporally prior SU and SUDs, the odds ratios (ORs) attenuated in all disorders while the associations with daily tobacco use, cannabis use, cocaine use and illicit drug abuse became non-significant. After additional adjustments with antecedent mental disorders (M3), those with life-time tobacco use [OR = 1.3, 95% confidence interval (CI) = 1.0-1.8], alcohol use (OR =1.4, 95% CI = 1.1-1.7) and extra-medical prescription drug use (OR = 1.5, 95% CI = 1.1-1.9) each had increased odds of subsequent onset of PEs. Unexpectedly, cannabis use was not associated with subsequent onset of PEs in the adjusted models. With respect to SUDs, alcohol use disorders (both alcohol abuse and alcohol dependence disorders) were associated with increased odds of subsequent PEs (alcohol abuse: OR =1.6, 95% CI = 1.2-2.2; alcohol dependence: OR = 1.5, 95% CI = 1.1-2.1).
Associations between psychotic experiences and later onset of SU/SUDs
In Table 3 we examined the associations between prior PEs and subsequent onset of SU/SUDs. In the multivariable base model (M1), temporally prior PEs were associated with increased odds of subsequent onset of all types of SU/SUDs. In the first multivariate models (M2), after adjusting for potential confounding factors (age-cohort, sex, person-years, country and temporally ordered SU/SUDs), the ORs for the associations attenuated, however, with additional adjustments with antecedent mental disorders (M3), those with temporally prior PEs had increased odds of subsequent tobacco use (OR = 1.5, 95% CI = 1.2-1.9), alcohol use (OR =1.3, 95% CI = 1.1-1.6) and cannabis use (OR =1.3, 95% CI = 1.0-1.5). Those with PEs also had increased odds of subsequent onset of nicotine dependence (OR =1.4, 95% CI = 1.1-2.0), alcohol abuse (OR =1.5, 95% CI = 1.2-2.0) and alcohol dependence (OR =1.4, 95% CI = 1.0-1.9) and illicit drug dependence (OR =1.5, 95% CI = 1.0-2.3).
When we repeated the survival models (M3) exploring the impact of severity of PEs on SU/SUDs that used PE type and PE annualized frequency metrics, we found a dose-response relationship between PEs and SU/SUDs (Table 4) . Those with two or more PE types (compared to one type) had elevated ORs for alcohol use, cannabis use, Table 3 Associations between temporally prior psychotic experiences (PEs) and subsequent onset of substance use (SU) and substance use disorders (SUDs). cocaine use and alcohol or illicit drug use disorders. The ORs ranged between 1.4 and 1.9 among those with life-time SU, and between 1.5 and 1.9 among those with SUDs. Similarly, those with more frequent PEs (compared to those with less frequent PEs) had increased odds of tobacco use, alcohol use, nicotine dependence, alcohol use disorders and illicit drug dependence, with similar gradients of risks as in PE types. When we repeated the survival models (M3) by restricting our sample within substance users only (as a post-hoc analysis), we found that PEs were associated with an increased odds of transition to alcohol abuse and alcohol use disorders (Supporting information, Table S3 ).
Multivariable (base) model (M1)
DISCUSSION
Using temporally ordered analyses, we confirm that the associations between SU/SUDs and PEs are bidirectional, and that these associations mainly persisted after accounting for other forms of prior SU/SUDs, demographic factors and a wide range of antecedent mental disorders. Because of the large sample size, we were also able to examine the specific nature of these associations across different types of both SUs and SUDs. In this way, we have extended our own research that showed significant bidirectional associations between PEs and certain types of SUDs (e.g. alcohol use disorders) [18] , and also previous research that focused upon cannabis use disorders only [19] .
Life-time tobacco use, extra-medical prescription drug use and alcohol use and alcohol use disorders were all associated with elevated odds of subsequent PEs after controlling for comorbid SU/SUDs and antecedent mental disorders. Similarly, temporally prior PEs were associated with subsequent onset of tobacco, alcohol and cannabis use and all SUDs. In addition, we found a dose-response relationship between PEs and subsequent onset of SU/SUDs with more types or greater number of PEs were associated with several SU/SUDs. The relationship persisted after controlling for a range of potential confounding factors.
When we restricted the analysis of PEs to predict SUDs among substance users, only the associations between PEs and alcohol disorders remained significant after adjusting for antecedent mental disorders. Although PEs were associated with an overall risk in SUDs, among those with substance use they did not make an additional contribution to the risk to other drug disorders or nicotine dependence, suggesting that the presence of PEs did not alter the odds of transitions from substance users to other drugs or nicotine use disorders.
We also found that the associations between SU/SUDs and PEs identified in multivariable models were attenuated after adjustment with 21 antecedent mental disorders. Table 4 Associations between psychotic experiences (PEs) (two or more versus one PE type, more than 0.3 annualized episodes versus 0.3 or less) and subsequent onset of substance use (SU) and substance use disorders (SUDs). This was not surprising, given that previous research suggested that prior PEs increased the risk of mental disorders later in life [20] , and given the extensive comorbidity between different types of substance use and mental disorders [31] . However, even after these adjustments, we identified appreciable ORs between several patterns of SU/SUDs and subsequent PEs and vice versa. These findings lend weight to the hypothesis that the presence of antecedent mental disorders does not account entirely for the relationship between SU/SUDs and PEs in either direction.
Although we found significant associations between cannabis use and subsequent onset of PEs in the bivariate model, this association did not persist after adjustment for the range of covariates we considered here, which included demographics, other temporally prior substance use and antecedent mental disorders. This is in contrast to cohort studies that included similar covariates [32] . This discrepancy may be due partly to methodological differences, as our analysis controlled for a much wider range of antecedent mental disorders than previous analyses, and excluded samples those with onset of PEs and SU/SUDs in the same year. Additionally, the mechanism of effect may be that cannabis induces PEs in those already vulnerable to developing such symptoms. We did not examine the ageat-onset of PEs among those who used (or did not use) substances, but previous research has suggested that cannabis may serve largely to decrease the age-at-onset of psychosis (rather than increasing incidence) [33] . PEs and substance use disorder may share common risk factors (e.g. traumatic life events, family history). Previous research found that the association between PEs and SUDs persisted after adjusting for trauma and victimization [4] .
Although a significant body of evidence has linked SU/SUDs with subsequent PEs, the biological mechanisms underpinning the association are yet to be established. Some commentators have suggested that substance use may contribute to dysregulation of dopamine neurotransmission which, in turn, may contribute to vulnerability to psychosis [34] . However, a recent meta-analysis with 24 studies found little evidence to suggest that cannabis use affects dopamine release in striatal and pre-frontal areas among healthy subjects [35] .
Several of the findings from this study warrant additional research, given their potential clinical and public health significance. First, the prevalence of SU/SUDs was higher among people who had experienced PEs, and further, that people who had experienced PEs also had greater odds of a range of different types of SUDs if they had engaged in use of any of the substances we examined here. The health risks of heavy tobacco use in particular are a concern, especially among more vulnerable and marginalized populations, which includes people with mental health problems, for whom it may also be more difficult to cease use. Secondly, once PEs have developed in an individual, the continued use of substances with psychoactive effects is of clinical concern, particularly in the case of alcohol and cannabis, which are the most commonly used substances. There is consistent evidence that continued substance use among people who have developed mental health problems increases risks for poorer mental health outcomes [36] . Our findings also provide a heuristic framework for the generation of new hypothesis related to PEs in future studies. For example, in light of the dose-response relationship between PEs and subsequent SU/SUDs, it will be of interest to see what proportion of early-versus lateonset PEs are linked to SU/SUDs and multiple use of substance use, as well as to explore if particular types of PEs (e.g. hallucinations, delusions) are associated differentially with particular types of SU/SUDs as a complex function of age at onset, time since onset and existence of complex comorbidities. As noted earlier, familial factors (e.g. genetic, shared environment) could confound the apparent relationships between the variables of interest [21] , in which case public health interventions designed to reduce the prevalence of exposure to SU/SUDs may not translate to reductions in the onset of subsequent PEs.
While the current study has several strengths (large sample size from many countries, consistent methods and standardized measures of data collection and temporally sequence the variables of interest), the study has several limitations. First, although we excluded people who were screen-positive for possible psychotic disorders, the WMH surveys were administered by lay interviewers, and clinical validation of CIDI diagnoses was not available. Respondents may underestimate their use of substances-this type of bias would reduce our ability to detect a true association between the variables of interest. Secondly, our studies were based on cross-sectional studies and retrospective reports about age-at-onset of PEs, SUDs and mental disorders which, although obtained rigorously [37] , would be subject to some level of recall bias. While we note that several prospective studies have confirmed the association between SUDs and PEs [1, 5, 19] , observational studies cannot determine causal pathways. Thirdly, our measure of cannabis use was onset of first-time use (not more frequent use), which may have contributed to our lack of significant findings between cannabis use and subsequent PEs. Moreover, the data did not allow us to measure cannabis use disorders in this study. Finally, it was also not possible to analyse those who had limited alcohol use versus heavy users because there were no separate questions for this in the WMH CIDI.
In summary, this study sheds new light upon the relationship between PEs and SU/SUDs. Although arguments continue whether SU/SUDs are associated causally with PEs [38] , our temporally ordered analysis confirms that the relationship between various SU/SUDs and PEs is bidirectional, and independent of antecedent mental disorders.
These findings have both clinical and public health significance, given that SU/SUDs and psychosis are important predictors of adverse health outcomes [39] . 
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